Dr. Nikos Gavalas

Research Scientist, Medical School, University of Athens-EKPA, Department of Clinical Therapeutics, Alexandra Hospital and ΑΤΤΙΚΟΝ University Hospital, 2nd Propaedeutic Dept. of Medicine, Athens, Greece

Dr. Nikos Gavalas is a Biologist by profession and interested in academic and applied research in Oncology, Immunology, Genomics, Proteomics, Autoimmunity and Endocrinology. He has developed an interest in Biobusiness, Healthcare transformation and economics, business models and strategic management aspects in healthcare, especially concerning its digital transformation.

His diverse profile comprises strong analytical, writing, technical, leadership skills with a background in biotechnology, basic and clinical research, biology, immunology, business management, research and development. He holds a PhD and an MBA and he is a Chartered Biologist, awarded by the Royal Society of Biology, UK.
His PhD dissertation consisted of work on molecular Endocrinology regarding cytokine antagonist construction, on growth hormone and leptin, targeting obesity and growth deficiencies like acromegaly.

His MBA dissertation consisted of analysis of business models regarding digital applications in healthcare and also strategic management aspects regarding these business models.
His has worked as a researcher in the UK (Sheffield, UK), and is currently working at the National and Kapodistrian University of Athens, Greece, on molecular Oncology and Cancer Immunology of solid and haematological tumors. He is also overlooking EU funded projects regarding education and science promotion.

He is interested in forming new partnerships, moving projects forward, promoting novel ideas, academic and applied research collaboration with research institutes and businesses at a worldwide level. He aims for establishing consortia for business alliances, high quality academic work, and knowledge promotion. Technologies application in healthcare and the value they can create is also of interest.

He is a member of scientific societies including the Society for Endcocrinology, UK, Society for Immunology, UK, where he has served as a Chairman of the Sheffield Region Affiliated group, the European Federation of Biotechnology, and the Royal Society of Biology, UK. He is also targeting for over 2000 citations for his academic work.